Health officials in several countries, including Britain and Norway, are recommending giving only one dose of the Pfizer vaccine to children aged 12 and under. The recommendation is based on data that suggests myocarditis may be more likely among young people after a second shot. (The New York Times)
Allogene’s clinical trial for its cell therapy ALLO-501A has been placed on hold by the Food and Drug Administration. A patient developed a “chromosomal abnormality” in CAR-T cells during the trial. (Endpoints News)
President Biden’s proposed new biomedical research agency has been cut from the Democrats’ reconciliation bill. The Advanced Research Projects Agency for Health was designed to provide research for conditions like cancer and Alzheimer’s disease. (Politico)
Neumora has received $500 million in funding from Arch Venture Partners and other investors to develop new pathways for psychiatric drugs. The company hopes to develop therapies for the central nervous system that target smaller populations of patients. (STAT)
New York state government agencies have fixed issues preventing blind or visually impaired people from accessing vaccination websites. The investigation found that vaccination websites at the federal, state and local levels violated disability rights laws. (Kaiser Health News)
